Enhertu
Drug timelines are a Plus or Pro feature.
95 regulatory and trial events tracked for Enhertu, covering 2019-12-20 to 2026-07-20. Get the full timeline:
Most recent: EMA Authorised: Enhertu (trastuzumab deruxtecan) — Daiichi Sankyo Europe GmbH